LX-RETATR · LUX PEAK
CATALOGUE
Retatrutide
$59CAD · PER VIAL
Triple-agonist tirzepatide-class peptide studied for metabolic and weight research.
1
CASH ON DELIVERY · TEXT OR CALL 604-305-0698
- Triple-agonist: GLP-1 / GIP / glucagon
- Lyophilized vial, reconstitute as needed
- Cold-chain shipped
ABOUT THIS PEPTIDE
Retatrutide is a next-generation triple-agonist peptide acting on GLP-1, GIP, and glucagon receptors. It sits in the same family as tirzepatide and semaglutide and is the subject of ongoing clinical research into glucose regulation, appetite signalling, and body composition.
For research use. Lux Peak does not provide medical advice. Speak to a qualified clinician before any protocol.
SPECIMEN
- FORM
- Lyophilized powder
- VIAL
- 5 mg
- STORAGE
- Refrigerated 2–8 °C
OFTEN PAIRED WITH
